Yes, the screening is completely safe and painless. It is non-invasive, requires no blood tests, and feels similar to a standard blood pressure check.
‍
What sets this screening apart is what happens with the data. The CardiAction platform combines advanced telemetry from the BP+ machine with key biometric inputs such as age, sex, height, and other factors to generate a more comprehensive cardiovascular risk profile. This includes insights into central blood pressure, arterial stiffness, cardiac workload and vascular resistance.
‍
The process may feel simple, but the analysis behind it is far more sophisticated than a regular blood pressure test, helping you better understand your cardiovascular event risk.

CardiAction screenings are available at selected participating pharmacies across Australia. To find your nearest location, please visit our Locations page.

The screening service costs $99 and includes your results delivered by email after your appointment.

Most screenings take around 20 minutes. To streamline your visit, please arrive a few minutes early and follow the preparation guidelines provided.

You can book online via our website or directly through a participating pharmacy. Walk-ins may be available, but we recommend confirming with the pharmacy in advance to ensure a screener is available.

Screenings are conducted by trained CardiAction Screening Australia (CSA) screeners, who follow approved protocols. They are not doctors or registered health practitioners and will not provide diagnosis, or medical advice.

The screening uses pulse wave analysis via the BP+ device to capture key data including:

This data, together with other key biometrics like your age and gender and then passed to the CardiAction platform which uses a proprietary algorithm to help determine your artery and heart health and Cohort Classification, which are designed to indicate your level of cardiovascular event risk and personalised recommended interventions to reduce your risk and improve your cardiovascular health.

No, CSA does not communicate directly with doctors or provide results to healthcare providers. However, your report can be shared with your GP. We strongly recommend speaking to your GP if your results suggest elevated risk.

Yes. For the most accurate results:

No. The CardiAction screening is a TGA-exempt health screening, not a medical consultation or diagnostic service. It does not provide medical advice or treatment. It is designed to support your health awareness and may indicate whether a medical follow-up is advisable.

After your screening, you will receive a personalised email report containing a set of results drawn from the CardiAction platform. These results include:

Your results will also include your Cohort Classification (0 to 3). This is used to group individuals into categories that reflect overall cardiovascular event risk and guides the recommended next steps.

Each cohort comes with personalised recommendations focused on improving heart and artery health. These may include advice on the urgency of seeking a GP consultation, lifestyle considerations, and when to consider a follow-up screening.

Your report is designed to be easy to understand and share with your GP or healthcare provider if further assessment is needed.

Please advise the screener at the start of your appointment. Your screening report does not interpret or evaluate your medications; only your doctor can do that.

If your results indicate an elevated risk of cardiovascular events, we recommend consulting your GP for a professional medical assessment and next steps.

Screeners are not authorised to provide personalised health or lifestyle advice. However, your CardiAction screening report does include tailored recommendations based on your individual results and Cohort Classification.

These may include suggestions relating to diet, physical activity, sleep, supplements, and other lifestyle factors shown to support heart and artery health. The report is designed to help you understand your cardiovascular profile and identify practical steps you can take to improve it.

If your results suggest elevated risk or you have any questions about the recommendations, we encourage you to discuss them with your GP.

Yes. Your personal information is handled securely and in accordance with our Privacy Policy and Terms of Use, as well as applicable Australian privacy laws.

Yes. Your personal information is handled securely and in accordance with our Privacy Policy and Terms of Use, as well as applicable Australian privacy laws.

We are committed to protecting your privacy and ensuring your information is used appropriately and responsibly in line with your express consent.

The CardiAction screening platform is TGA-exempt under Australian regulations. CardiAction Pty Ltd has formally applied for and received exemption status from the Therapeutic Goods Administration. This exemption applies because the platform does not provide a diagnosis or medical treatment. It is a non-diagnostic health screening tool designed to support awareness of cardiovascular event risk, rather than disease status.

The screening uses a TGA-registered medical device (the BP+ machine) to collect advanced pulse wave data, including central blood pressure, arterial stiffness, and cardiac efficiency indicators. This data alone is not enough

What makes the screening unique is the CardiAction platform, which combines the data from the BP+ device with other biometric information such as your age, sex and height. A scientifically developed and independently validated algorithm developed over more than a decade is then applied to generate your personalised results.

Your report includes a detailed explanation of your cardiovascular profile, your Cohort Classification, and suggested next steps to support your heart and artery health.

In summary, the BP+ device provides clinically validated measurements, and the CardiAction platform turns those into meaningful insights through an approved and compliant screening process.

We recommend annual screenings as a general guide. If your results suggest moderate or high risk, or you’ve made health changes, re-screening in 3 to 6 months may be beneficial. Speak with your CSA screener for a personalised recommendation.

Yes. CSA offers group screening packages for community events and businesses. Contact us for more information on tailored solutions.